A new way to cross the blood–brain barrier
04 December, 2024The blood–brain barrier-crossing conjugate (BCC) system is designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system.
Oxytocin analogue treats chronic abdominal pain
29 November, 2024Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain, based on the peptide hormone known as oxytocin.
Three-in-one pill could transform hypertension treatment
28 November, 2024Australian research has produced impressive Phase III clinical trial results for an innovative combination of drugs, which could revolutionise the management of high blood pressure.
FDA approves new treatment for graft-versus-host disease
19 November, 2024Back in 2014, Dr Kelli MacDonald's lab at QIMR Berghofer identified the cellular process causing chronic GVHD as well as the antibody that could block this process.
Drug delays tumour growth in models of children's liver cancer
15 November, 2024A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma, a type of liver cancer that occurs in young children.
Cancer drug eliminates bone metastasis in lab models
08 November, 2024Researchers have developed a novel treatment that is specific to breast cancer bone metastasis and can successfully work in the bone microenvironment, which is often resistant to therapeutics.
TGA rejects Alzheimer's drug due to safety concerns
07 November, 2024The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did not outweigh the safety risks associated with its use.
Towards safer epilepsy treatment for pregnant women
29 October, 2024New research conducted in organoids is expected to provide pregnant women with epilepsy safer access to a common and highly effective anti-seizure medication.
Epilepsy drug shows promise for obstructive sleep apnoea
15 October, 2024Sulthiame, a drug currently in use for epilepsy, has been shown to reduce symptoms of obstructive sleep apnoea (OSA), according to the results of a recent clinical trial.
FDA approves schizophrenia drug with new mechanism of action
27 September, 2024 by Lauren DavisThe antipsychotic drug targets cholinergic receptors as opposed to dopamine receptors, making it the first in an entirely new class of drug for patients with schizophrenia in more than 70 years.
Cannabidiol alleviates symptoms of rare mitochondrial disease
26 September, 2024Daily administration of cannabidiol, a substance obtained from the cannabis plant, extends lifespan and improves symptoms associated with Leigh syndrome in animal models.
Implant could encourage healing after spinal cord injury
20 September, 2024When electrical stimulation is applied to the implant, it can convey that electrical signal to boost the regrowth of the injured axons.
Ultrasound device offers non-invasive treatment of chronic pain
18 September, 2024Diadem is a biomedical device that uses ultrasound to non-invasively stimulate deep brain regions, disrupting the faulty signals that lead to chronic pain.
Gene therapy trial results in significant vision improvements
17 September, 2024The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was anywhere from 100 to 10,000 times better after they received gene therapy.
Non-hormonal drug treats hot flashes in menopausal women
06 September, 2024The investigational drug elinzanetant has been found to reduce the frequency and severity of hot flashes associated with menopause while improving women's sleep and quality of life.
